Beyond the science

Using technology-enabled services to accelerate
decision making and drive efficiency gains

#TogetherBEYONDCOVID19 #AskTheExpert Are you Brexit ready? See how we can help.

A specialized biopharma service

The merger with Biopharma Excellence enables PharmaLex to provide high value services in biopharmaceuticals and integrated product development

Post-approval / Maintenance

Post Market Product Maintenance: the one-stop global full service solution for pharma & biotech companies

SMARTPHLEX - Leading technological innovation

SMARTPHLEX – technology-enabled services

Combining expert knowledge and new technologies to deliver market leading solutions

Together Beyond COVID-19

The race starts here – PharmaLex outlines its key services which will enable you to be ready to respond

PharmaLex is a leading provider of specialized services for the pharma, biotech and medtech industries

We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide.

The PharmaLex Group now has over 1400 employees, with 41 offices in 22 countries and more than 600 satisfied clients worldwide.